GANGAPHARM.BO
Price:
$11.68
Market Cap:
$69.05M
Ganga Pharmaceuticals Ltd. engages in the manufacturing and trading of pharmaceuticals and allied products. It focuses on manufacturing, marketing, and distribution of Bulk Ayurvedic medicines. Its products include Ampachan Vati, Khadira Vati, and Nirmalaya churna. The firm offers acidity, antidandruff, antioxidants, constipation, dental care, diarrhea, ear care, female tonic, and joint pains ayurvedic medicines. The company was founded by Brijmohan C. Sharma in 1974 and is headquartered in Mumbai, India.
Industry
Medical - Pharmaceuticals
IPO Date
Stock Exchange
BSE
Ticker
GANGAPHARM.BO
According to Ganga Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current PE Ratio is 106.18. This represents a change of 17.06% compared to the average of 90.71 of the last 4 quarters.
The mean historical PE Ratio of Ganga Pharmaceuticals Limited over the last ten years is 133.81. The current 106.18 PE Ratio has changed 7.84% with respect to the historical average. Over the past ten years (40 quarters), GANGAPHARM.BO's PE Ratio was at its highest in in the March 2016 quarter at 973.10. The PE Ratio was at its lowest in in the September 2019 quarter at 10.28.
Average
133.81
Median
109.23
Minimum
33.15
Maximum
335.84
Discovering the peaks and valleys of Ganga Pharmaceuticals Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 820.00%
Maximum Annual PE Ratio = 335.84
Minimum Annual Increase = -68.93%
Minimum Annual PE Ratio = 33.15
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 104.35 | -68.93% |
| 2024 | 335.84 | 149.98% |
| 2023 | 134.35 | 17.74% |
| 2022 | 114.11 | -62.59% |
| 2021 | 305.00 | 820.00% |
| 2020 | 33.15 | 0.00% |
| 2019 | 33.15 | -50.00% |
| 2018 | 66.30 | -21.74% |
| 2017 | 84.72 | -33.33% |
| 2016 | 127.08 | 9.16% |
The current PE Ratio of Ganga Pharmaceuticals Limited (GANGAPHARM.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
191.51
5-year avg
198.73
10-year avg
133.81
Ganga Pharmaceuticals Limited’s PE Ratio is
| Company | PE Ratio | Market cap |
|---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ganga Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ganga Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Ganga Pharmaceuticals Limited's PE Ratio?
How is the PE Ratio calculated for Ganga Pharmaceuticals Limited (GANGAPHARM.BO)?
What is the highest PE Ratio for Ganga Pharmaceuticals Limited (GANGAPHARM.BO)?
What is the 3-year average PE Ratio for Ganga Pharmaceuticals Limited (GANGAPHARM.BO)?
What is the 5-year average PE Ratio for Ganga Pharmaceuticals Limited (GANGAPHARM.BO)?
How does the current PE Ratio for Ganga Pharmaceuticals Limited (GANGAPHARM.BO) compare to its historical average?